purchase customization

1 Study Coverage
1.1 Anti-Hypertensive Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Diuretics
1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.4 Angiotensin Receptor Blockers (ARBs)
1.2.5 Calcium Channel Blockers
1.2.6 Beta Blockers
1.2.7 Alpha Blockers
1.2.8 Vasodilators
1.2.9 Renin Inhibitors
1.3 Market by Application
1.3.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-Hypertensive Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-Hypertensive Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-Hypertensive Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-Hypertensive Drugs Sales by Region
2.4.1 Global Anti-Hypertensive Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Anti-Hypertensive Drugs by Region (2023-2028)
2.5 Global Anti-Hypertensive Drugs Revenue by Region
2.5.1 Global Anti-Hypertensive Drugs Revenue by Region (2017-2022)
2.5.2 Global Anti-Hypertensive Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-Hypertensive Drugs Sales by Manufacturers
3.1.1 Global Top Anti-Hypertensive Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-Hypertensive Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Hypertensive Drugs in 2021
3.2 Global Anti-Hypertensive Drugs Revenue by Manufacturers
3.2.1 Global Anti-Hypertensive Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-Hypertensive Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Hypertensive Drugs Revenue in 2021
3.3 Global Anti-Hypertensive Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-Hypertensive Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-Hypertensive Drugs Sales by Type
4.1.1 Global Anti-Hypertensive Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Anti-Hypertensive Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-Hypertensive Drugs Sales Market Share by Type (2017-2028)
4.2 Global Anti-Hypertensive Drugs Revenue by Type
4.2.1 Global Anti-Hypertensive Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-Hypertensive Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-Hypertensive Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Anti-Hypertensive Drugs Price by Type
4.3.1 Global Anti-Hypertensive Drugs Price by Type (2017-2022)
4.3.2 Global Anti-Hypertensive Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-Hypertensive Drugs Sales by Application
5.1.1 Global Anti-Hypertensive Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Anti-Hypertensive Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-Hypertensive Drugs Sales Market Share by Application (2017-2028)
5.2 Global Anti-Hypertensive Drugs Revenue by Application
5.2.1 Global Anti-Hypertensive Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-Hypertensive Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-Hypertensive Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Anti-Hypertensive Drugs Price by Application
5.3.1 Global Anti-Hypertensive Drugs Price by Application (2017-2022)
5.3.2 Global Anti-Hypertensive Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-Hypertensive Drugs Market Size by Type
6.1.1 North America Anti-Hypertensive Drugs Sales by Type (2017-2028)
6.1.2 North America Anti-Hypertensive Drugs Revenue by Type (2017-2028)
6.2 North America Anti-Hypertensive Drugs Market Size by Application
6.2.1 North America Anti-Hypertensive Drugs Sales by Application (2017-2028)
6.2.2 North America Anti-Hypertensive Drugs Revenue by Application (2017-2028)
6.3 North America Anti-Hypertensive Drugs Market Size by Country
6.3.1 North America Anti-Hypertensive Drugs Sales by Country (2017-2028)
6.3.2 North America Anti-Hypertensive Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-Hypertensive Drugs Market Size by Type
7.1.1 Europe Anti-Hypertensive Drugs Sales by Type (2017-2028)
7.1.2 Europe Anti-Hypertensive Drugs Revenue by Type (2017-2028)
7.2 Europe Anti-Hypertensive Drugs Market Size by Application
7.2.1 Europe Anti-Hypertensive Drugs Sales by Application (2017-2028)
7.2.2 Europe Anti-Hypertensive Drugs Revenue by Application (2017-2028)
7.3 Europe Anti-Hypertensive Drugs Market Size by Country
7.3.1 Europe Anti-Hypertensive Drugs Sales by Country (2017-2028)
7.3.2 Europe Anti-Hypertensive Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-Hypertensive Drugs Market Size by Type
8.1.1 Asia Pacific Anti-Hypertensive Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-Hypertensive Drugs Market Size by Application
8.2.1 Asia Pacific Anti-Hypertensive Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-Hypertensive Drugs Market Size by Region
8.3.1 Asia Pacific Anti-Hypertensive Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anti-Hypertensive Drugs Market Size by Type
9.1.1 Latin America Anti-Hypertensive Drugs Sales by Type (2017-2028)
9.1.2 Latin America Anti-Hypertensive Drugs Revenue by Type (2017-2028)
9.2 Latin America Anti-Hypertensive Drugs Market Size by Application
9.2.1 Latin America Anti-Hypertensive Drugs Sales by Application (2017-2028)
9.2.2 Latin America Anti-Hypertensive Drugs Revenue by Application (2017-2028)
9.3 Latin America Anti-Hypertensive Drugs Market Size by Country
9.3.1 Latin America Anti-Hypertensive Drugs Sales by Country (2017-2028)
9.3.2 Latin America Anti-Hypertensive Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-Hypertensive Drugs Market Size by Type
10.1.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-Hypertensive Drugs Market Size by Application
10.2.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-Hypertensive Drugs Market Size by Country
10.3.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Anti-Hypertensive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Anti-Hypertensive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Anti-Hypertensive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Anti-Hypertensive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Anti-Hypertensive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Johnson & Johnson Anti-Hypertensive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Anti-Hypertensive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Anti-Hypertensive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Lupin
11.5.1 Lupin Corporation Information
11.5.2 Lupin Overview
11.5.3 Lupin Anti-Hypertensive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Lupin Anti-Hypertensive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lupin Recent Developments
11.6 Ranbaxy Laboratories
11.6.1 Ranbaxy Laboratories Corporation Information
11.6.2 Ranbaxy Laboratories Overview
11.6.3 Ranbaxy Laboratories Anti-Hypertensive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ranbaxy Laboratories Anti-Hypertensive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ranbaxy Laboratories Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Overview
11.7.3 Merck Anti-Hypertensive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Anti-Hypertensive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Anti-Hypertensive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AstraZeneca Anti-Hypertensive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca Recent Developments
11.9 Daiichi Sankyo Company Limited
11.9.1 Daiichi Sankyo Company Limited Corporation Information
11.9.2 Daiichi Sankyo Company Limited Overview
11.9.3 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Daiichi Sankyo Company Limited Recent Developments
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Corporation Information
11.10.2 Takeda Pharmaceutical Overview
11.10.3 Takeda Pharmaceutical Anti-Hypertensive Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Takeda Pharmaceutical Anti-Hypertensive Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takeda Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-Hypertensive Drugs Industry Chain Analysis
12.2 Anti-Hypertensive Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Hypertensive Drugs Production Mode & Process
12.4 Anti-Hypertensive Drugs Sales and Marketing
12.4.1 Anti-Hypertensive Drugs Sales Channels
12.4.2 Anti-Hypertensive Drugs Distributors
12.5 Anti-Hypertensive Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-Hypertensive Drugs Industry Trends
13.2 Anti-Hypertensive Drugs Market Drivers
13.3 Anti-Hypertensive Drugs Market Challenges
13.4 Anti-Hypertensive Drugs Market Restraints
14 Key Findings in The Global Anti-Hypertensive Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer